HK185396A - Bcrf1 proteins as inhibitors of interferon--g(g) - Google Patents
Bcrf1 proteins as inhibitors of interferon--g(g)Info
- Publication number
- HK185396A HK185396A HK185396A HK185396A HK185396A HK 185396 A HK185396 A HK 185396A HK 185396 A HK185396 A HK 185396A HK 185396 A HK185396 A HK 185396A HK 185396 A HK185396 A HK 185396A
- Authority
- HK
- Hong Kong
- Prior art keywords
- interferon
- inhibitors
- bcrf1
- proteins
- bcrf1 proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45393189A | 1989-12-20 | 1989-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK185396A true HK185396A (en) | 1996-10-11 |
Family
ID=23802631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK185396A HK185396A (en) | 1989-12-20 | 1996-01-03 | Bcrf1 proteins as inhibitors of interferon--g(g) |
Country Status (27)
Country | Link |
---|---|
US (2) | US5627155A (de) |
EP (1) | EP0506836B1 (de) |
JP (1) | JP2648236B2 (de) |
KR (1) | KR960015199B1 (de) |
CN (1) | CN1057012C (de) |
AT (1) | ATE112317T1 (de) |
AU (1) | AU7899694A (de) |
CA (1) | CA2071907C (de) |
CZ (1) | CZ283049B6 (de) |
DE (1) | DE69013011T2 (de) |
DK (1) | DK0506836T3 (de) |
ES (1) | ES2064082T3 (de) |
FI (1) | FI104883B (de) |
HK (1) | HK185396A (de) |
HU (1) | HU215909B (de) |
IE (1) | IE72203B1 (de) |
IL (1) | IL96715A0 (de) |
MX (1) | MX9203409A (de) |
MY (1) | MY107449A (de) |
NO (1) | NO305703B1 (de) |
NZ (1) | NZ236512A (de) |
OA (1) | OA09703A (de) |
PH (1) | PH31669A (de) |
PT (1) | PT96231B (de) |
SK (1) | SK635190A3 (de) |
WO (1) | WO1991009127A1 (de) |
ZA (1) | ZA9010188B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
JPH04505019A (ja) * | 1989-10-23 | 1992-09-03 | シェリング・コーポレーション | ガンマインターフェロンのポリペプチド性阻害剤 |
US6106823A (en) * | 1991-01-16 | 2000-08-22 | Schering Corporation | Treatment of neoplastic disease with interleukin-10 |
JP3260368B2 (ja) * | 1991-01-16 | 2002-02-25 | シェリング・コーポレーション | インターロイキン−10による腫瘍性疾患の処置 |
CZ281796B6 (cs) * | 1991-08-06 | 1997-02-12 | Schering Corporation | Použití interleukinu-10, jeho analoga, agonisty nebo antagonisty pro výrobu léčiva a farmaceutický přípravek je obsahující |
US5833976A (en) * | 1991-08-06 | 1998-11-10 | Schering Corporation | Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity |
US6008327A (en) | 1992-03-13 | 1999-12-28 | Akzo Nobel, N.V. | Peptides and nucleic acid sequences related to the Epstein Barr virus |
EP1225226B1 (de) * | 1992-03-13 | 2007-12-05 | bioMerieux B.V. | Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente |
WO1993018783A1 (en) * | 1992-03-20 | 1993-09-30 | Schering Corporation | Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
DE69330966T2 (de) * | 1993-07-23 | 2002-06-06 | Wolf, Hans | DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests |
US5616724A (en) * | 1996-02-21 | 1997-04-01 | Cephalon, Inc. | Fused pyrrolo[2,3-c]carbazole-6-ones |
JP2001512830A (ja) * | 1997-08-08 | 2001-08-28 | ニューバイオティックス インコーポレイテッド | 生物療法耐性および化学療法耐性を克服するための方法および組成物 |
EP2791168A1 (de) | 2011-11-23 | 2014-10-22 | Amgen Inc. | Behandlungsverfahren unter verwendung eines antikörpers gegen interferon-gamma |
WO2022016509A1 (zh) * | 2020-07-24 | 2022-01-27 | 阎忠扬 | 一种用以筛选药物的方法,以及该药物用于治疗牛皮癣的用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3583564D1 (de) * | 1984-08-23 | 1991-08-29 | Hans Joachim Wolf | Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten. |
US5256768A (en) * | 1985-12-13 | 1993-10-26 | The Johns Hopkins University | Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics |
-
1990
- 1990-12-18 WO PCT/US1990/007288 patent/WO1991009127A1/en active IP Right Grant
- 1990-12-18 SK SK6351-90A patent/SK635190A3/sk unknown
- 1990-12-18 JP JP3502513A patent/JP2648236B2/ja not_active Expired - Fee Related
- 1990-12-18 DK DK91902258.2T patent/DK0506836T3/da active
- 1990-12-18 ES ES91902258T patent/ES2064082T3/es not_active Expired - Lifetime
- 1990-12-18 NZ NZ236512A patent/NZ236512A/en unknown
- 1990-12-18 EP EP91902258A patent/EP0506836B1/de not_active Expired - Lifetime
- 1990-12-18 AT AT91902258T patent/ATE112317T1/de not_active IP Right Cessation
- 1990-12-18 CA CA002071907A patent/CA2071907C/en not_active Expired - Fee Related
- 1990-12-18 ZA ZA9010188A patent/ZA9010188B/xx unknown
- 1990-12-18 KR KR1019920701474A patent/KR960015199B1/ko not_active IP Right Cessation
- 1990-12-18 IL IL96715A patent/IL96715A0/xx unknown
- 1990-12-18 HU HU9202075A patent/HU215909B/hu not_active IP Right Cessation
- 1990-12-18 PT PT96231A patent/PT96231B/pt not_active IP Right Cessation
- 1990-12-18 MX MX9203409A patent/MX9203409A/es unknown
- 1990-12-18 PH PH41744A patent/PH31669A/en unknown
- 1990-12-18 DE DE69013011T patent/DE69013011T2/de not_active Expired - Fee Related
- 1990-12-18 CZ CS906351A patent/CZ283049B6/cs not_active IP Right Cessation
- 1990-12-19 CN CN90110079A patent/CN1057012C/zh not_active Expired - Fee Related
- 1990-12-19 MY MYPI90002207A patent/MY107449A/en unknown
- 1990-12-19 IE IE458890A patent/IE72203B1/en not_active IP Right Cessation
-
1992
- 1992-06-16 FI FI922770A patent/FI104883B/fi active
- 1992-06-19 NO NO922456A patent/NO305703B1/no not_active IP Right Cessation
- 1992-06-19 OA OA60232A patent/OA09703A/en unknown
-
1994
- 1994-11-23 AU AU78996/94A patent/AU7899694A/en not_active Abandoned
-
1995
- 1995-05-26 US US08/450,749 patent/US5627155A/en not_active Expired - Lifetime
- 1995-06-06 US US08/466,950 patent/US5736390A/en not_active Expired - Lifetime
-
1996
- 1996-01-03 HK HK185396A patent/HK185396A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0335901A4 (en) | Methods and compositions for the treatment of non-ige-mediated diseases | |
ES8602768A1 (es) | Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas. | |
HK185396A (en) | Bcrf1 proteins as inhibitors of interferon--g(g) | |
RO90639B (ro) | Procedeu pentru prepararea tesutului uman activator de plasminogen | |
IL119461A (en) | 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines | |
CA2193993A1 (en) | New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4 | |
GR1002486B (el) | Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της. | |
ES482097A1 (es) | Procedimiento para preparar derivados acilicos de carnitina. | |
DE69130679D1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
HU9201799D0 (en) | New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments | |
EP0273310A3 (de) | 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva | |
IL99940A0 (en) | Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same | |
ATE168698T1 (de) | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten | |
TW372873B (en) | A novel anti-neoplastic cytokine | |
ES8200886A1 (es) | Procedimiento para la preparacion de derivados del amino-1 propanol-2 | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
HUT39599A (en) | Process for producing compositions stimulating growth of hair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20041218 |